Cuba will be tested in cancer drug
- Submitted by: Luis Manuel Mazorra
- Health and Medicine
- 12 / 09 / 2011
A researcher at the Center of Molecular Immunology (CIM) reported that an investigation will take an entire island in paragraph ProBar created Eight New Drug Against Cancer, which were created on the island.
National Products son clearly designed from the molecule in the Laboratories of CIM, and their production in plants, said a Prensa Latina, Mayra Ramos, head of the Department of Clinical Trials of the institution.
Among the drugs developed by the center if they find the nimotuzumab, THE CIMAVAX-EGF, 'ganglioside-based vaccines, the vaccine and the racotumomab HER1, which are used in different indications such as lung cancer, breast, prostate, cervix, the anal canal and rectum, indicated the Scientific.
Another substance to be tested is the Itolizumab For Treatment of autoimmune diseases as rheumatoid arthritis, psoriasis, diabetes and other diseases.
At present, the CIM develops Clinical Trials 60, 20 of which child in other countries, she said during the V International Workshop on Design and Conduct of Clinical Trials, which sits on This capital, from 5 to December 7.
One of the most significant studies is that conducted in Cuba and Latin America on the cervical cancer is that a major cause of death from the disease in the nations of the region, said Ramos.
Professionals Working in the Design and Conduct of Clinical Trials, monitors and attendants Several Countries discuss about these types of jobs, Ethics and Technology to support them.
Presentations on Quality Assurance, Regulatory Policies and Their Implications for clinical trials, among other topics, given in the discussions of the event.
The clinical study is the experimental evaluation of the UN product, substance or drug promising application in humans Whose aims assess its effectiveness, and the level of safety, experts stressed.